Schizophrenia drug study probes cell power plants
NCT ID NCT06236451
First seen Oct 31, 2025 · Last updated May 01, 2026 · Updated 23 times
Summary
This study looked at how two schizophrenia medications, risperidone and aripiprazole, affect the energy-producing parts of cells (mitochondria) in 60 patients. Researchers measured changes in cell energy markers over 12 weeks. The goal was to better understand drug side effects, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
All India Institute of Medical Sciences (AIIMS)
Bhubaneswar, Odisha, 751019, India
Conditions
Explore the condition pages connected to this study.